| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e8ba3a78c8071e7102ecfb3c3ffc02d7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_046b94174ff188b5b5d0c4605583ee11 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D285-135
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D285-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-443 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-443
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D285-135 |
| filingDate |
2013-12-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4948e6e8b2bfc72426c43f40d0784569
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f5ce3af237bb6d7c3debd125f991b0dc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_92818cd99d316345b8122c9a6bfff9a5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8904a0c0adadd424154349fa6cc4405b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e1a0a0a3f10c2bf723b228b21e95d9cd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6ee1535000e7caddd34f8507df9687f8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_094d268aec41a7535c079d4fed49911c |
| publicationDate |
2015-02-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2015016442-A1 |
| titleOfInvention |
Novel phenylthiazole-based hydroxamic acid and anti-cancer composition containing same as active ingredient |
| abstract |
The present invention relates to a novel phenylthiazole-based hydroxamic acid compound and an anti-cancer composition containing same as an active ingredient. A hydroxamic acid compound according to the present invention exhibits anti-cancer effects by having histone deacetylase (HDAC) inhibition activity and cytotoxicity in various cancer cells, and thus can be developed into a powerful active ingredient for an anti-cancer agent. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-115368277-A |
| priorityDate |
2013-07-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |